Generic Clarinex Reditabs® Launch

Released: 01/28/2013   By: Mike Partridge, RPh

On January 23, 2013, Dr. Reddy’s Laboratories commenced shipping the generic equivalent for Merck’s branded product, Clarinex Reditabs® (desloratadine ODT) tablets. Clarinex Reditabs® had estimated total U.S. annual sales of approximately $7 million.
Clarinex Reditabs® is an antihistamine indicated for the relief of the nasal and nonnasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older.